Skip to main content
. 2016 Aug 22;2(6):767–782.e6. doi: 10.1016/j.jcmgh.2016.08.001

Supplementary Table 2.

The Primary Antibodies Used in the Present Study

Company Catalog no Dilution
Alkaline phosphatase Rockland, Limerick, PA 200-4135 1:2000
β-actin Santa Cruz, Dallas, TX sc-1616 1:1000
β-catenin BD Biosciences, San Jose, CA 610154 1:50
BrdU Sigma-Aldrich, St. Louis, MO B2531 1:1000
Chromogranin A Abcam, Cambridge, United Kingdom ab15160 1:100
Dll1 R&D Systems, Minneapolis, MN AF5026 1:500
E-cadherin BD Biosciences, San Jose, CA c20820-050 1:200
FITC-phalloidin Sigma-Aldrich, St. Louis, MO P5282 1:1000
Gnaq/Gna11 Abcam, Cambridge, United Kingdom ab79337 1:200
Hes-1 Santa Cruz, Dallas, TX sc-25392 1:150
Hes-5 Millipore, Darmstadt, Germany AB5708 1:200
Ki-67 Cell Signaling, Danvers, MA 12202 1:800
Lysozyme Dako, Glostrup, Denmark A0099U2 1:1000
Muc2 Santa Cruz, Dallas, TX sc-15334 1:200
Notch1 Abcam, Cambridge, United Kingdom ab27526 1:200
Phospho-PKC (pan) Cell Signaling, Danvers, MA 9371 1:1000
Sox9 Millipore, Darmstadt, Germany AB5535 1:200
Tcf1 Cell Signaling, Danvers, MA 2203 1:100

FITC, fluorescein isothiocyanate.